Gilead Sciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $38.09B | $56.98B | $8.23B |
| FY2017 | $49.84B | $70.28B | $7.59B |
| FY2018 | $42.29B | $63.68B | $17.94B |
| FY2019 | $39.10B | $61.63B | $11.63B |
| FY2020 | $50.21B | $68.41B | $6.00B |